Synapse - Works

Results (5611)

Feasibility of administering anti-CD45 iodine ((131)I) apamistamab [Iomab-B] for re-induction and targeted conditioning in older patients with active, relapsed or refractory AML without lead-lined rooms: SIERRA trial experience at MSKCC

Meeting Abstract

Chu, B. P.; Pandit-Taskar, N.; Gyurkocza, B.; Liang, Q.; Miodownik, D.; Reddy, V.; Berger, M. S.; Dauer, L. T.
Blood (2019)

Fulltext@MSK | Save

Phase 1 trial of K0706, a novel oral BCR-ABL1 tyrosine kinase inhibitor (TKI): In patients with chronic myelogenous leukemia (CML) and phildelphia positive acute lymphoblastic leukemia (Ph + ALL) failing ≥ 3 prior TKI therapies: Initial safety and efficacy

Meeting Abstract

Cortes, J. E.; Kim, D. W.; Nicolini, F. E.; Saikia, T.; Charbonnier, A.; Apperley, J. F.; Rathnam, K.; Deininger, M. W.; De Lavallade, H.; Khattry, N.; more...
Blood (2019)

Fulltext@MSK | Save

Outcomes of 210 patients with follicular and marginal zone lymphomas treated with 4 Gy of radiation therapy

Meeting Abstract

Chau, K.; Imber, B.; Joffe, E.; Yang, J. C.; Chelius, M.; Doyle, C.; Hajj, C.; Yahalom, J.
Blood (2019)

Fulltext@MSK | Save

Outpatient BEAM using daily etoposide and cytarabine with autologous hematopoietic stem cell transplantation for lymphoma is feasible and decreases inpatient length of stay

Meeting Abstract

Cazeau, N.; Cavalier, K.; Bhatt, V.; McElrath, C.; Lestrange, N.; Lachaud-Richard, M.; Inumerables, F.; Andrejko, M.; Batalha, J.; Cohen, A.; more...
Blood (2019)

Fulltext@MSK | Save

FT819: Translation of off-the-shelf TCR-less TRAC-1XX CAR-T cells in support of first-of-kind phase I clinical trial

Meeting Abstract

Chang, C.; Van Der Stegen, S.; Mili, M.; Clarke, R.; Lai, Y. S.; Witty, A.; Lindenbergh, P.; Yang, B. H.; Husain, M.; Shaked, H.; more...
Blood (2019)

Fulltext@MSK | Save

Plasmacytoid dendritic cell proportion is predictive of risk and outcomes in myelodysplastic syndromes

Meeting Abstract

Chan, A.; Zhang, Y.; Devlin, S. M.; Lewis, N.; Baik, J.; Arcila, M. E.; Klimek, V. M.; Roshal, M.; Xiao, W.
Blood (2019)

Fulltext@MSK | Save

Potent synergy between combination of chimeric antigen receptor (CAR) therapy targeting CD19 in conjunction with dendritic cell (DC)/tumor fusion vaccine in hematological malignancies

Meeting Abstract

Capelletti, M.; Liegel, J.; Themeli, M.; Mutis, T.; Stroopinsky, D.; Orr, S.; Torres, D.; Morin, A.; Gunset, G.; Ghiasuddin, H.; more...
Blood (2019)

Fulltext@MSK | Save

Newly diagnosed AML patient samples demonstrate high degree of concordance in identification of pathogenic mutations by next generation sequencing (NGS) performed at enrolling institutions compared to central laboratory results in the Beat AML Master Trial

Meeting Abstract

Borate, U.; Ruppert, A. S.; Yang, F.; Jones, D.; Caruthers, S.; Zhao, W.; Vergilio, J. A.; Burd, A.; Pavlick, D.; Juckett, L.; more...
Blood (2019)

Fulltext@MSK | Save

Targeted sequencing predicts the development of myeloid malignancies and clinical outcome in patients with unexplained cytopenia

Meeting Abstract

Cargo, C.; Bolton, K.; Beinortas, T.; Glover, P.; Short, M.; Smith, A.; Taylor, J.; Evans, P. A. S.; Papaemmanuil, E.; Crouch, S.
Blood (2019)

Fulltext@MSK | Save

Time to second treatment as a proxy for overall survival in CLL/SLL: Identifying risk factors to help guide treatment selection

Meeting Abstract

Bantilan, K. S.; Soumerai, J. D.; Roeker, L. E.; Mato, A. R.; Zelenetz, A. D.
Blood (2019)

Fulltext@MSK | Save